Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05690269 · ClinicalTrials.gov registry record

Oximeters and Skin Pigment: Impact of Skin Pigmentation on Accuracy of Pulse Oximetry

A clinical trial of Hypoxemia and Hyperoxia, sponsored by University of Cincinnati.

Completed
Registry status
232
Enrollment target
1
Study location

NCT05690269 is a study of Hypoxemia and Hyperoxia that has completed, run by University of Cincinnati. The registered enrollment target is 232 participants, below the 472-participant average among 10 other Hypoxemia trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05690269, a study of Hypoxemia and Hyperoxia, has completed, sponsored by University of Cincinnati.

COMPLETED
Registry status
232 participants
Enrollment target
1
Study location

Study Summary

Finger pulse oximetry SpO2 is widely used to estimate arterial oxygen saturation SaO2. Current Spo2 targets do not take into consideration the many variables that affect that correlation in particular skin pigmentation. This study aims to evaluate different FDA approved pulse oximeters (Nonin co-pilot, massimo Radical 7, Philips-standard of care monitor, innovo premium iP900BP, nellcor PM1000N, Nano100) with SaO2 reference values obtained by an arterial blood gas in subjects with different skin pigments measured by a skin color scale as well as self-identification of race.

Interventions

  • DEVICE SpO2 and SaO2 comparison

Study Locations (1)

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2023-02-27
Est. Completion 2025-03-31

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT05690269

The ClinicalTrials.gov registry entry for NCT05690269 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 472-participant average among 10 other Hypoxemia trials with a reported enrollment target (51% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypoxemia appearing as the primary indexed condition, and to 1 intervention - of which SpO2 and SaO2 comparison is the first listed.

NCT05690269 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05690269 about?

NCT05690269 is a clinical study titled "Oximeters and Skin Pigment: Impact of Skin Pigmentation on Accuracy of Pulse Oximetry". Finger pulse oximetry SpO2 is widely used to estimate arterial oxygen saturation SaO2. Current Spo2 targets do not take into consideration the many variables that affect that correlation in particular skin pigmentation. This study aims to evaluate different FDA approved pulse oximeters (Nonin co-pi...

What is the current status of trial NCT05690269?

This trial is currently completed. The enrollment target is 232 participants. The study started on 2023-02-27. Estimated completion is 2025-03-31.

What conditions does trial NCT05690269 study?

This clinical trial studies the following conditions: Hypoxemia, Hyperoxia, Pigment Skin.

What interventions are being tested in trial NCT05690269?

The interventions under investigation include: SpO2 and SaO2 comparison (DEVICE).

Who is sponsoring clinical trial NCT05690269?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05690269 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.